Emergent BioSolutions Inc.EBS
What Emergent BioSolutions Inc. does.
We are a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate and naturally occurring Public Health Threats (“PHTs”). Our solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing (“CDMO”) services portfolio. The types of PHTs we are currently addressing are focused on the following four categories:
Our revenues are derived from a combination of the sale and procurement of our product/product candidate portfolio (described below), the provision of our bioservices to external customers, and non-dilutive contract and grant funding for research and development ( “ R&D ” ) projects from various third-party sources.
As of December 31, 2025, the Company has a portfolio of 11 products focused on addressing global public health threats like smallpox, mpox, anthrax, Ebola and opioid overdose emergencies. The revenues generated by the products comprise a substantial portion of our revenue. We structure our business with a focus on markets and customers. As such, the key components of the business structure include the following four product and service categories: Commercial products, consisting of NARCAN ® Nasal Spray and KLOXXADO ® , Anthrax – Medical Countermeasures (“MCM”) Products, Smallpox - MCM products, and Emergent Bioservices (CDMO) (“Bioservices”).
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.8B | $1.1B | $1.0B | $1.0B | $742.9M |
| Net income | $305.8M | $219.5M | -$211.6M | -$760.5M | -$190.6M | $52.6M |
| Free cash flow | $395.0M | $96.1M | -$149.9M | -$257.9M | $35.8M | $156.8M |
More on EBS.
- Emergent BioSolutions Inc. summary
- Emergent BioSolutions Inc. financial statements
- Emergent BioSolutions Inc. key metrics
- Emergent BioSolutions Inc. health scores and style box
- Emergent BioSolutions Inc. earnings
- Emergent BioSolutions Inc. dividends
- Emergent BioSolutions Inc. valuation
- Emergent BioSolutions Inc. ownership and insiders
- Emergent BioSolutions Inc. peers
Figures from Emergent BioSolutions Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.